Barbara Klencke - Apr 6, 2023 Form 4 Insider Report for TScan Therapeutics, Inc. (TCRX)

Role
Director
Signature
/s/ Barbara Klencke
Stock symbol
TCRX
Transactions as of
Apr 6, 2023
Transactions value $
$0
Form type
4
Date filed
4/10/2023, 10:39 AM
Previous filing
Jan 24, 2023
Next filing
Jun 15, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TCRX Stock Option (Right to Buy) Award $0 +9.15K $0.00 9.15K Apr 6, 2023 Voting Common Stock 9.15K $2.20 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to this option shall vest and become exercisable in thirty-six equal monthly installments following April 6, 2023, subject to the Reporting Person's continued service at such time.